Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA030669 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA030669, RRID:AB_10601163
- Product name
- Anti-SLCO4A1
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human SLCO4A1, Gene description: solute carrier organic anion transporter family, member 4A1, Alternative Gene Names: OATP-E, OATP4A1, SLC21A12, Validated applications: IHC, Uniprot ID: Q96BD0, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.3 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Single-cell image analysis reveals over-expression of organic anion transporting polypeptides (OATPs) in human glioblastoma tissue
SLCO4A1 expression is associated with activated inflammatory pathways in high-grade serous ovarian cancer
Two common polymorphic variants of OATP4A1 as potential risk factors for colorectal cancer
Cooper E, Woolf Z, Swanson M, Correia J, Schweder P, Mee E, Heppner P, Turner C, Faull R, Scotter E, Denny W, Choi P, Dragunow M, Jose J, Park T
Neuro-Oncology Advances 2022;4(1)
Neuro-Oncology Advances 2022;4(1)
SLCO4A1 expression is associated with activated inflammatory pathways in high-grade serous ovarian cancer
Koller S, Kendler J, Karacs J, Wolf A, Kreuzinger C, Von Der Decken I, Mungenast F, Mechtcheriakova D, Schreiner W, Gleiss A, Jäger W, Cacsire Castillo-Tong D, Thalhammer T
Frontiers in Pharmacology 2022;13
Frontiers in Pharmacology 2022;13
Two common polymorphic variants of OATP4A1 as potential risk factors for colorectal cancer
Buxhofer‑Ausch V, Német O, Sheikh M, Andrikovics H, Reiner A, Ausch C, Mechtcheriakova D, Tordai A, Gleiss A, Özvegy‑laczka C, Jäger W, Thalhammer T
Oncology Letters 2020;20(5):1-1
Oncology Letters 2020;20(5):1-1
No comments: Submit comment
No validations: Submit validation data